Wyne P Lee Selected Research

Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)

12/2010	Actin-bundling protein L-plastin regulates T cell activation.
4/2004	NTB-A, a new activating receptor in T cells that regulates autoimmune disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wyne P Lee Research Topics

Disease

20	Inflammation (Inflammations) 10/2022 - 06/2007
14	Asthma (Bronchial Asthma) 10/2022 - 12/2007
10	Neoplasms (Cancer) 01/2020 - 01/2005
6	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 06/2015
5	Arthritis (Polyarthritis) 01/2020 - 06/2007
5	Infections 01/2016 - 06/2010
4	Experimental Arthritis 01/2019 - 06/2007
4	Autoimmune Diseases (Autoimmune Disease) 06/2015 - 04/2004
3	Pneumonia (Pneumonitis) 11/2018 - 12/2013
3	Atrophy 08/2018 - 01/2018
3	Sepsis (Septicemia) 01/2018 - 07/2004
3	Choroidal Neovascularization 02/2016 - 03/2008
2	Pain (Aches) 01/2021 - 01/2021
2	Necrosis 11/2020 - 01/2018
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2019 - 01/2017
2	Respiratory Hypersensitivity 11/2018 - 12/2015
2	Proteinuria 01/2017 - 01/2015
2	Rheumatoid Arthritis 12/2015 - 01/2011
2	Disease Progression 01/2015 - 06/2007
2	Human Influenza (Influenza) 07/2014 - 07/2013
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 12/2010 - 04/2004
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2007 - 09/2005
2	Lymphoma (Lymphomas) 09/2005 - 01/2005
2	Shock 07/2004 - 07/2004
1	Eosinophilia 01/2022
1	Edema (Dropsy) 01/2021
1	Glomerulonephritis 01/2021
1	Cough 01/2021
1	Neuralgia (Stump Neuralgia) 01/2021
1	Autoimmune Lymphoproliferative Syndrome 11/2020
1	Bites and Stings (Sting) 01/2020
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Colitis 01/2020
1	Anaphylaxis (Anaphylactic Shock) 10/2019
1	Hereditary Neoplastic Syndromes (Cancer Syndrome, Hereditary) 01/2019

Drug/Important Bio-Agent (IBA)

10	CytokinesIBA 10/2022 - 01/2011
7	AntibodiesIBA 01/2016 - 12/2007
6	Phosphotransferases (Kinase)IBA 01/2020 - 12/2015
5	Proteins (Proteins, Gene)FDA Link 01/2017 - 04/2004
4	LipopolysaccharidesIBA 10/2015 - 07/2004
3	AllergensIBA 01/2022 - 12/2013
3	OvalbuminIBA 01/2021 - 12/2015
3	Immunoglobulin E (IgE)IBA 10/2019 - 06/2010
3	Interleukin-17 (Interleukin 17)IBA 01/2019 - 07/2009
3	Deubiquitinating EnzymesIBA 01/2019 - 12/2015
3	Interleukin-4 (Interleukin 4)IBA 11/2018 - 04/2004
3	Complement System Proteins (Complement)IBA 01/2018 - 06/2007
3	AntigensIBA 12/2015 - 04/2004
2	Biomarkers (Surrogate Marker)IBA 10/2022 - 10/2019
2	Peptide Hydrolases (Proteases)FDA Link 10/2022 - 12/2013
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 11/2018
2	LigandsIBA 01/2021 - 11/2020
2	Antigen-Antibody Complex (Immune Complex)IBA 01/2021 - 01/2017
2	AutoantibodiesIBA 01/2021 - 01/2011
2	Caspase 8 (Caspase-8)IBA 11/2020 - 01/2018
2	Tryptases (Tryptase)IBA 01/2020 - 10/2019
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020 - 04/2017
2	CollagenIBA 01/2020 - 01/2019
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019 - 04/2017
2	Retinaldehyde (Retinal)IBA 08/2018 - 01/2018
2	CaspasesIBA 01/2018 - 01/2017
2	Pharmaceutical PreparationsIBA 01/2018 - 10/2009
2	Interleukin-22 (IL-22)IBA 01/2017 - 10/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 03/2008
2	OX40 LigandIBA 01/2017 - 12/2007
2	UbiquitinIBA 04/2016 - 12/2015
2	Interferon-gamma (Interferon, gamma)IBA 07/2009 - 04/2004
2	dacetuzumabIBA 08/2006 - 09/2005
1	Kallikreins (Kallikrein)IBA 10/2022
1	PeriostinIBA 10/2022
1	Neutralizing AntibodiesIBA 10/2022
1	Hyaluronic Acid (Hyaluronan)IBA 01/2022
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2022
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2022
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2022
1	Fluticasone (Cutivate)FDA LinkGeneric 01/2022
1	SteroidsIBA 01/2022
1	tetrahydrofuranIBA 01/2021
1	Transient Receptor Potential ChannelsIBA 01/2021
1	compound 20IBA 01/2021
1	GDC-0334IBA 01/2021
1	SymportersIBA 01/2021
1	2,3,4-tri-O-acetylarabinopyranosyl isothiocyanate (AITC)IBA 01/2021
1	Ion Channels (Ion Channel)IBA 01/2021
1	CalciumIBA 01/2021
1	AnkyrinsIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Death Domain ReceptorsIBA 11/2020
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2020
1	sharpinIBA 01/2020
1	Interferon Type IIBA 01/2020
1	IgG Receptors (Fc gamma RI)IBA 01/2020
1	Adenosine Triphosphate (ATP)IBA 01/2020
1	c-Mer Tyrosine KinaseIBA 01/2020
1	Antigen Receptors (Antigen Receptor)IBA 01/2020
1	anti-IgE antibodiesIBA 10/2019
1	LaccaseIBA 01/2019

Therapy/Procedure

6	Therapeutics 01/2022 - 08/2006
2	Immunotherapy 01/2020 - 01/2005
2	Lasers (Laser) 08/2013 - 03/2008